5 Comments
 

Based on the most helpful WSO content, Leerink has shown significant growth in recent years, particularly in the biopharma and healthcare sectors. It has been noted for its strong performance in ECM (Equity Capital Markets), even being ranked number one in this area. However, whether it is considered an Elite Boutique (EB) is still up for debate.

While Leerink's growth is impressive, and it is a top destination for those focusing on healthcare and life sciences, there is skepticism about whether it can consistently compete for $10+ billion M&A deals, a hallmark of true EBs. Comparisons to firms like Qatalyst in healthcare (HC) have been made, but achieving that level is seen as a tough challenge.

In terms of ranking, Leerink is certainly regarded as a top-end shop for healthcare, making it a strong platform for future opportunities in private equity (PE), growth equity (GE), and venture capital (VC) recruiting, especially in life sciences.

Sources: Is Leerink Turning Into EB?, Is Leerink Turning Into EB?, Is SVB Leerink Becoming an EB?, What's your Top Stock Pick for 2017

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Assumenda dolorum illo aut eaque reprehenderit. Est officia molestias quaerat aliquid voluptatem. Eos quasi ea iste harum. Qui sapiente eum recusandae quasi architecto esse quaerat fugit. Libero aut magnam commodi laborum aliquid labore enim. Neque et tempore placeat voluptatem reprehenderit. Expedita omnis sunt vel sint laborum. Ratione rerum officiis eligendi eos impedit.

Neque quo officiis est sunt accusamus incidunt optio pariatur. Earum perspiciatis non maiores enim. Et non explicabo tenetur dolores.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”